期刊中(zhong)文名:抗衰老醫學ISSN:2475-0360
該(gai)雜志國(guo)(guo)際簡稱:AGING MED-PRC,是由出版(ban)商Wiley出版(ban)的一本致力于發布--研(yan)究新成(cheng)(cheng)果(guo)的的專業學(xue)(xue)術期刊。主要發表(biao)刊登有(you)創見的學(xue)(xue)術論(lun)(lun)文文章、行業最(zui)新科研(yan)成(cheng)(cheng)果(guo),扼要報道(dao)階段性研(yan)究成(cheng)(cheng)果(guo)和重要研(yan)究工作的最(zui)新進展(zhan),選載對(dui)學(xue)(xue)科發展(zhan)起指導作用的綜(zong)述與專論(lun)(lun),促進學(xue)(xue)術發展(zhan),為廣大讀者服務。該(gai)刊是一本國(guo)(guo)際優秀(xiu)雜志,在國(guo)(guo)際上(shang)有(you)很高(gao)的學(xue)(xue)術影響力。
《Aging Medicine》是一本(ben)以(yi)English為主的(de)開放(fang)獲(huo)取(qu)國際(ji)優秀期刊(kan)(kan),中文名稱抗衰(shuai)老醫學(xue),本(ben)刊(kan)(kan)主要出版(ban)、報道領(ling)域的(de)研究動態(tai)以(yi)及在(zai)該(gai)領(ling)域取(qu)得的(de)各方(fang)面的(de)經驗和科研成果,介紹該(gai)領(ling)域有關本(ben)專業的(de)最新(xin)進(jin)(jin)展(zhan)(zhan),探討行業發(fa)展(zhan)(zhan)的(de)思路和方(fang)法,以(yi)促進(jin)(jin)學(xue)術信(xin)息交流,提高行業發(fa)展(zhan)(zhan)。該(gai)刊(kan)(kan)已被國際(ji)權(quan)威數(shu)據庫SCIE收錄,為該(gai)領(ling)域相(xiang)關學(xue)科的(de)發(fa)展(zhan)(zhan)起到了(le)良好的(de)推動作用,也得到了(le)本(ben)專業人(ren)員的(de)廣泛認(ren)可。該(gai)刊(kan)(kan)最新(xin)影響因子為2.2,最新(xin)CiteScore 指(zhi)數(shu)為4.1。
Aging Medicine is an international academic journal dedicated to the field of geriatric medicine, sponsored by Beijing Hospital and the National Geriatric Center, and guided by the Geriatric Branch of the Chinese Medical Association. This magazine is published by the internationally renowned publishing group Wiley, aiming to publish high-quality original research, review articles, and academic reviews related to the health of the elderly. The research content of the magazine is extensive, covering the prevention, clinical diagnosis and treatment, rehabilitation, care, psychology, and society of diseases in the elderly. It is committed to promoting the development of geriatric medicine to address the challenges of global population aging.
The journal implements strict peer review, and all published articles are open access, ensuring that senior medical practitioners worldwide can access, download, and share these research results for free. The target readers of the journal include senior medical researchers, clinical doctors, policy makers, as well as scholars and the public interested in elderly health. Journals promote academic collaboration and knowledge sharing on a global scale by providing an international academic exchange platform. In addition, the journal also provides efficient and convenient services for researchers by optimizing the review process and improving the speed of article publication. It plans to hold more international academic conferences and symposiums to promote academic exchange and cooperation. Its editorial department is committed to maintaining high-quality publishing standards and plans to further strengthen international cooperation, attract more top scholars to submit articles, and increase attention to hot topics and cutting-edge research, promoting the continuous progress of geriatric medicine research.
按JIF指(zhi)標學科分區 |
學科:GERIATRICS & GERONTOLOGY
收錄子集:ESCI
分區:Q3
排名:48 / 74
百分位:
35.8% |
按(an)JCI指標學科分區 |
學科:GERIATRICS & GERONTOLOGY
收錄子集:ESCI
分區:Q4
排名:59 / 74
百分位:
20.95% |
JCR分區:JCR分(fen)(fen)(fen)區(qu)來自科(ke)(ke)睿唯(wei)安公司(si),JCR是(shi)一(yi)個(ge)(ge)獨(du)特的多學(xue)科(ke)(ke)期刊(kan)(kan)評價工具,為唯(wei)一(yi)提供基于引文數據的統計信息的期刊(kan)(kan)評價資源(yuan)。每年發布的JCR分(fen)(fen)(fen)區(qu),設置(zhi)了254個(ge)(ge)具體學(xue)科(ke)(ke)。JCR分(fen)(fen)(fen)區(qu)根據每個(ge)(ge)學(xue)科(ke)(ke)分(fen)(fen)(fen)類(lei)按照(zhao)期刊(kan)(kan)當年的影響因(yin)子高低將期刊(kan)(kan)平(ping)均(jun)分(fen)(fen)(fen)為4個(ge)(ge)區(qu),分(fen)(fen)(fen)別為Q1、Q2、Q3和Q4,各占25%。JCR分(fen)(fen)(fen)區(qu)中期刊(kan)(kan)的數量是(shi)均(jun)勻分(fen)(fen)(fen)為四(si)個(ge)(ge)部(bu)分(fen)(fen)(fen)的。
學科類別 | 分區 | 排名 | 百分位 |
大類:Medicine 小類:Geriatrics and Gerontology | Q3 | 59 / 116 |
49% |
大類:Medicine 小類:Aging | Q3 | 28 / 38 |
27% |
該雜(za)志是一(yi)本(ben)國際優秀(xiu)雜(za)志,在(zai)國際上(shang)有較(jiao)高(gao)(gao)的(de)學術影響力,行業(ye)關注度(du)很(hen)高(gao)(gao),已被(bei)國際權威數據庫SCIE收(shou)錄,該雜(za)志在(zai)綜合專(zhuan)業(ye)領域專(zhuan)業(ye)度(du)認可很(hen)高(gao)(gao),對稿(gao)件內容的(de)創新性和學術性要求(qiu)很(hen)高(gao)(gao),作為一(yi)本(ben)國際優秀(xiu)雜(za)志,一(yi)般投(tou)(tou)稿(gao)過審時(shi)間(jian)都較(jiao)長,投(tou)(tou)稿(gao)過審時(shi)間(jian)平(ping)均(jun) 12 Weeks ,如(ru)果想(xiang)投(tou)(tou)稿(gao)該刊要做好時(shi)間(jian)安排。版面費不祥。該雜(za)志近兩年(nian)未被(bei)列入預警名單,建議您投(tou)(tou)稿(gao)。如(ru)您想(xiang)了(le)解更多投(tou)(tou)稿(gao)政(zheng)策及(ji)投(tou)(tou)稿(gao)方案,請咨詢(xun)客服。
若用戶需(xu)要出版服(fu)務,請(qing)聯系出版商。